BIZZARI JEAN-PIERRE 4
4 · Aprea Therapeutics, Inc. · Filed Aug 24, 2023
Insider Transaction Report
Form 4
BIZZARI JEAN-PIERRE
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-08-23+12,500→ 12,500 totalExercise: $3.65Exp: 2033-08-23→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]These options shall vest in full on the two year anniversary of the grant date, subject to the reporting person's continued service on the Issuer's board of Directors through and including the applicable vesting date.